Isabel Meininger

发表

Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity

G. Popowicz, M. Sattler, D. Krappmann, 2018, The Journal of Biological Chemistry.

Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome

D. Krappmann, Isabel Meininger, 2016, Biological chemistry.

Tissue-Specific Features of Innate Lymphoid Cells.

J. Mjösberg, Isabel Meininger, A. Carrasco, 2020, Trends in immunology.

MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.

G. Lenz, D. Krappmann, S. Hauck, 2019, Cell reports.

MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation

M. Gaestel, T. Kamradt, I. Irmler, 2016, The Journal of Immunology.

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells

F. Greten, B. Nieswandt, T. Herdegen, 2015, Oncotarget.

Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.

D. Krappmann, Frederick M. Tomlin, Isabel Meininger, 2016, ACS medicinal chemistry letters.

IL‐33‐activated murine mast cells control the dichotomy between RORγt+ and Helios+ Tregs via the MK2/3‐mediated IL‐6 production in vitro

M. Gaestel, T. Kamradt, Isabel Meininger, 2019, European journal of immunology.

Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells

F. Heyd, J. Ruland, A. Gewies, 2016, Nature Communications.

Modulation of pre-mRNA structure by hnRNP proteins regulates alternative splicing of MALT1

M. Sattler, D. Krappmann, A. Geerlof, 2021, bioRxiv.